カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアルファ-1 プロテイナーゼ阻害剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Alpha-1 Proteinase Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19114）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19114
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアルファ-1 プロテイナーゼ阻害剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アルファ-1 プロテイナーゼ阻害剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアルファ-1 プロテイナーゼ阻害剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アルファ-1 プロテイナーゼ阻害剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・溶液、粉末

用途別セグメントは次のように区分されます。
・病院、診療所

世界のアルファ-1 プロテイナーゼ阻害剤市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、Kamada、Grifols、CSL Behring

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アルファ-1 プロテイナーゼ阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアルファ-1 プロテイナーゼ阻害剤メーカーの企業概要、2019年～2022年までのアルファ-1 プロテイナーゼ阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアルファ-1 プロテイナーゼ阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アルファ-1 プロテイナーゼ阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアルファ-1 プロテイナーゼ阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアルファ-1 プロテイナーゼ阻害剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアルファ-1 プロテイナーゼ阻害剤の産業チェーンを掲載しています。
・第13、14、15章では、アルファ-1 プロテイナーゼ阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アルファ-1 プロテイナーゼ阻害剤の概要
- 種類別分析（2017年vs2021年vs2028年）：溶液、粉末
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所
- 世界のアルファ-1 プロテイナーゼ阻害剤市場規模・予測
- 世界のアルファ-1 プロテイナーゼ阻害剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Takeda、Kamada、Grifols、CSL Behring
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：溶液、粉末
・用途別分析2017年-2028年：病院、診療所
・アルファ-1 プロテイナーゼ阻害剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アルファ-1 プロテイナーゼ阻害剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アルファ-1 プロテイナーゼ阻害剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アルファ-1 プロテイナーゼ阻害剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アルファ-1 プロテイナーゼ阻害剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Alpha-1 Proteinase Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Alpha-1 Proteinase Inhibitor market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Alpha-1 Proteinase Inhibitor global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solution segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Alpha-1 Proteinase Inhibitor include Takeda, Kamada, Grifols, CSL Behring, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Alpha-1 Proteinase Inhibitor market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solution
Powder
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Alpha-1 Proteinase Inhibitor market are listed below:
Takeda
Kamada
Grifols
CSL Behring
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha-1 Proteinase Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha-1 Proteinase Inhibitor, with price, sales, revenue and global market share of Alpha-1 Proteinase Inhibitor from 2019 to 2022.
Chapter 3, the Alpha-1 Proteinase Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha-1 Proteinase Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Alpha-1 Proteinase Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alpha-1 Proteinase Inhibitor.
Chapter 13, 14, and 15, to describe Alpha-1 Proteinase Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Alpha-1 Proteinase Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha-1 Proteinase Inhibitor Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Solution
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha-1 Proteinase Inhibitor Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Alpha-1 Proteinase Inhibitor Market Size & Forecast
1.4.1 Global Alpha-1 Proteinase Inhibitor Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Alpha-1 Proteinase Inhibitor Sales in Volume (2017-2028)
1.4.3 Global Alpha-1 Proteinase Inhibitor Price (2017-2028)
1.5 Global Alpha-1 Proteinase Inhibitor Production Capacity Analysis
1.5.1 Global Alpha-1 Proteinase Inhibitor Total Production Capacity (2017-2028)
1.5.2 Global Alpha-1 Proteinase Inhibitor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha-1 Proteinase Inhibitor Market Drivers
1.6.2 Alpha-1 Proteinase Inhibitor Market Restraints
1.6.3 Alpha-1 Proteinase Inhibitor Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Alpha-1 Proteinase Inhibitor Product and Services
2.1.4 Takeda Alpha-1 Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Kamada
2.2.1 Kamada Details
2.2.2 Kamada Major Business
2.2.3 Kamada Alpha-1 Proteinase Inhibitor Product and Services
2.2.4 Kamada Alpha-1 Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Alpha-1 Proteinase Inhibitor Product and Services
2.3.4 Grifols Alpha-1 Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL Behring
2.4.1 CSL Behring Details
2.4.2 CSL Behring Major Business
2.4.3 CSL Behring Alpha-1 Proteinase Inhibitor Product and Services
2.4.4 CSL Behring Alpha-1 Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Alpha-1 Proteinase Inhibitor Breakdown Data by Manufacturer
3.1 Global Alpha-1 Proteinase Inhibitor Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Alpha-1 Proteinase Inhibitor Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Alpha-1 Proteinase Inhibitor
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha-1 Proteinase Inhibitor Manufacturer Market Share in 2021
3.4.2 Top 6 Alpha-1 Proteinase Inhibitor Manufacturer Market Share in 2021
3.5 Global Alpha-1 Proteinase Inhibitor Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Alpha-1 Proteinase Inhibitor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alpha-1 Proteinase Inhibitor Market Size by Region
4.1.1 Global Alpha-1 Proteinase Inhibitor Sales in Volume by Region (2017-2028)
4.1.2 Global Alpha-1 Proteinase Inhibitor Revenue by Region (2017-2028)
4.2 North America Alpha-1 Proteinase Inhibitor Revenue (2017-2028)
4.3 Europe Alpha-1 Proteinase Inhibitor Revenue (2017-2028)
4.4 Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue (2017-2028)
4.5 South America Alpha-1 Proteinase Inhibitor Revenue (2017-2028)
4.6 Middle East and Africa Alpha-1 Proteinase Inhibitor Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Alpha-1 Proteinase Inhibitor Sales in Volume by Type (2017-2028)
5.2 Global Alpha-1 Proteinase Inhibitor Revenue by Type (2017-2028)
5.3 Global Alpha-1 Proteinase Inhibitor Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Alpha-1 Proteinase Inhibitor Sales in Volume by Application (2017-2028)
6.2 Global Alpha-1 Proteinase Inhibitor Revenue by Application (2017-2028)
6.3 Global Alpha-1 Proteinase Inhibitor Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Alpha-1 Proteinase Inhibitor Sales by Type (2017-2028)
7.2 North America Alpha-1 Proteinase Inhibitor Sales by Application (2017-2028)
7.3 North America Alpha-1 Proteinase Inhibitor Market Size by Country
7.3.1 North America Alpha-1 Proteinase Inhibitor Sales in Volume by Country (2017-2028)
7.3.2 North America Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Alpha-1 Proteinase Inhibitor Sales by Type (2017-2028)
8.2 Europe Alpha-1 Proteinase Inhibitor Sales by Application (2017-2028)
8.3 Europe Alpha-1 Proteinase Inhibitor Market Size by Country
8.3.1 Europe Alpha-1 Proteinase Inhibitor Sales in Volume by Country (2017-2028)
8.3.2 Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Type (2017-2028)
9.2 Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Application (2017-2028)
9.3 Asia-Pacific Alpha-1 Proteinase Inhibitor Market Size by Region
9.3.1 Asia-Pacific Alpha-1 Proteinase Inhibitor Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Alpha-1 Proteinase Inhibitor Sales by Type (2017-2028)
10.2 South America Alpha-1 Proteinase Inhibitor Sales by Application (2017-2028)
10.3 South America Alpha-1 Proteinase Inhibitor Market Size by Country
10.3.1 South America Alpha-1 Proteinase Inhibitor Sales in Volume by Country (2017-2028)
10.3.2 South America Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Type (2017-2028)
11.2 Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Application (2017-2028)
11.3 Middle East & Africa Alpha-1 Proteinase Inhibitor Market Size by Country
11.3.1 Middle East & Africa Alpha-1 Proteinase Inhibitor Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Alpha-1 Proteinase Inhibitor and Key Manufacturers
12.2 Manufacturing Costs Percentage of Alpha-1 Proteinase Inhibitor
12.3 Alpha-1 Proteinase Inhibitor Production Process
12.4 Alpha-1 Proteinase Inhibitor Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Alpha-1 Proteinase Inhibitor Typical Distributors
13.3 Alpha-1 Proteinase Inhibitor Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Alpha-1 Proteinase Inhibitor Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Alpha-1 Proteinase Inhibitor Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Alpha-1 Proteinase Inhibitor Product and Services
Table 6. Takeda Alpha-1 Proteinase Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Kamada Basic Information, Manufacturing Base and Competitors
Table 8. Kamada Major Business
Table 9. Kamada Alpha-1 Proteinase Inhibitor Product and Services
Table 10. Kamada Alpha-1 Proteinase Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Grifols Basic Information, Manufacturing Base and Competitors
Table 12. Grifols Major Business
Table 13. Grifols Alpha-1 Proteinase Inhibitor Product and Services
Table 14. Grifols Alpha-1 Proteinase Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 16. CSL Behring Major Business
Table 17. CSL Behring Alpha-1 Proteinase Inhibitor Product and Services
Table 18. CSL Behring Alpha-1 Proteinase Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Alpha-1 Proteinase Inhibitor Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Alpha-1 Proteinase Inhibitor Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Alpha-1 Proteinase Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Alpha-1 Proteinase Inhibitor Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Alpha-1 Proteinase Inhibitor Production Site of Key Manufacturer
Table 24. Alpha-1 Proteinase Inhibitor New Entrant and Capacity Expansion Plans
Table 25. Alpha-1 Proteinase Inhibitor Mergers & Acquisitions in the Past Five Years
Table 26. Global Alpha-1 Proteinase Inhibitor Sales by Region (2017-2022) & (K Units)
Table 27. Global Alpha-1 Proteinase Inhibitor Sales by Region (2023-2028) & (K Units)
Table 28. Global Alpha-1 Proteinase Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Alpha-1 Proteinase Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 31. Global Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 32. Global Alpha-1 Proteinase Inhibitor Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Alpha-1 Proteinase Inhibitor Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Alpha-1 Proteinase Inhibitor Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Alpha-1 Proteinase Inhibitor Price by Type (2023-2028) & (US$/Unit)
Table 36. Global Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 37. Global Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 38. Global Alpha-1 Proteinase Inhibitor Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Alpha-1 Proteinase Inhibitor Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Alpha-1 Proteinase Inhibitor Price by Application (2017-2022) & (US$/Unit)
Table 41. Global Alpha-1 Proteinase Inhibitor Price by Application (2023-2028) & (US$/Unit)
Table 42. North America Alpha-1 Proteinase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 43. North America Alpha-1 Proteinase Inhibitor Sales by Country (2023-2028) & (K Units)
Table 44. North America Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Alpha-1 Proteinase Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 47. North America Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 48. North America Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 49. North America Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 50. Europe Alpha-1 Proteinase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 51. Europe Alpha-1 Proteinase Inhibitor Sales by Country (2023-2028) & (K Units)
Table 52. Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 55. Europe Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 56. Europe Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 57. Europe Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 66. South America Alpha-1 Proteinase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 67. South America Alpha-1 Proteinase Inhibitor Sales by Country (2023-2028) & (K Units)
Table 68. South America Alpha-1 Proteinase Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Alpha-1 Proteinase Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 71. South America Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 72. South America Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 73. South America Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Alpha-1 Proteinase Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Alpha-1 Proteinase Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales by Application (2023-2028) & (K Units)
Table 82. Alpha-1 Proteinase Inhibitor Raw Material
Table 83. Key Manufacturers of Alpha-1 Proteinase Inhibitor Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Alpha-1 Proteinase Inhibitor Typical Distributors
Table 87. Alpha-1 Proteinase Inhibitor Typical Customers
List of Figures
Figure 1. Alpha-1 Proteinase Inhibitor Picture
Figure 2. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Type in 2021
Figure 3. Solution
Figure 4. Powder
Figure 5. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Alpha-1 Proteinase Inhibitor Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Alpha-1 Proteinase Inhibitor Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Alpha-1 Proteinase Inhibitor Sales (2017-2028) & (K Units)
Figure 11. Global Alpha-1 Proteinase Inhibitor Price (2017-2028) & (US$/Unit)
Figure 12. Global Alpha-1 Proteinase Inhibitor Production Capacity (2017-2028) & (K Units)
Figure 13. Global Alpha-1 Proteinase Inhibitor Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Alpha-1 Proteinase Inhibitor Market Drivers
Figure 15. Alpha-1 Proteinase Inhibitor Market Restraints
Figure 16. Alpha-1 Proteinase Inhibitor Market Trends
Figure 17. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Manufacturer in 2021
Figure 18. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Manufacturer in 2021
Figure 19. Alpha-1 Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Alpha-1 Proteinase Inhibitor Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Alpha-1 Proteinase Inhibitor Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2017-2028)
Figure 23. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2017-2028)
Figure 24. North America Alpha-1 Proteinase Inhibitor Revenue (2017-2028) & (USD Million)
Figure 25. Europe Alpha-1 Proteinase Inhibitor Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue (2017-2028) & (USD Million)
Figure 27. South America Alpha-1 Proteinase Inhibitor Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Alpha-1 Proteinase Inhibitor Revenue (2017-2028) & (USD Million)
Figure 29. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2017-2028)
Figure 30. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
Figure 31. Global Alpha-1 Proteinase Inhibitor Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 33. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
Figure 34. Global Alpha-1 Proteinase Inhibitor Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2017-2028)
Figure 36. North America Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 37. North America Alpha-1 Proteinase Inhibitor Sales Market Share by Country (2017-2028)
Figure 38. North America Alpha-1 Proteinase Inhibitor Revenue Market Share by Country (2017-2028)
Figure 39. United States Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2017-2028)
Figure 43. Europe Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 44. Europe Alpha-1 Proteinase Inhibitor Sales Market Share by Country (2017-2028)
Figure 45. Europe Alpha-1 Proteinase Inhibitor Revenue Market Share by Country (2017-2028)
Figure 46. Germany Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2017-2028)
Figure 55. China Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2017-2028)
Figure 62. South America Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 63. South America Alpha-1 Proteinase Inhibitor Sales Market Share by Country (2017-2028)
Figure 64. South America Alpha-1 Proteinase Inhibitor Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Alpha-1 Proteinase Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Alpha-1 Proteinase Inhibitor in 2021
Figure 76. Manufacturing Process Analysis of Alpha-1 Proteinase Inhibitor
Figure 77. Alpha-1 Proteinase Inhibitor Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアルファ L-イズロニダーゼ市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のプラスミノーゲンアクチベーターインヒビター1市場2022年：市場規模予測（～2028年）
  • 経口用JAK1阻害剤のグローバル市場展望 2023年-2029年：ブランド、バイオシミラー
  • 世界の抗レトロウイルスプロテアーゼ阻害剤市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19114 )"世界のアルファ-1 プロテイナーゼ阻害剤市場2022年：市場規模予測（～2028年）" (英文：Global Alpha-1 Proteinase Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。